Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 23.30
-1.40 (-5.67%)
Mar 9, 2026, 1:30 PM CST
Orient Pharma Revenue
Orient Pharma had revenue of 316.12M TWD in the quarter ending September 30, 2025, a decrease of -3.34%. This brings the company's revenue in the last twelve months to 1.28B, up 12.59% year-over-year. In the year 2024, Orient Pharma had annual revenue of 1.22B with 37.41% growth.
Revenue (ttm)
1.28B
Revenue Growth
+12.59%
P/S Ratio
4.70
Revenue / Employee
7.39M
Employees
173
Market Cap
6.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 332.90M | 37.41% |
| Dec 31, 2023 | 889.91M | 378.05M | 73.86% |
| Dec 31, 2022 | 511.86M | 48.52M | 10.47% |
| Dec 31, 2021 | 463.34M | 51.33M | 12.46% |
| Dec 31, 2020 | 412.01M | 58.47M | 16.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SCI Pharmtech | 1.34B |
| Formosa Laboratories | 4.90B |
| Orient EuroPharma | 4.53B |
| LIWANLI Innovation | 125.54M |
| Easywell Biomedicals | 588.89M |
| Merdury Biopharmaceutical | 246.00K |
| Standard Chemical & Pharmaceutical | 7.02B |
| Maywufa Company | 1.58B |